InvestLog
TSHA logo

TSHA

Taysha Gene Therapies, Inc.NASDAQHealthcare
$4.37+1.39%ClosedMarket Cap: $1.09B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-19Chardan Capital—Buy—
2026-03-19Needham—Buy—
2026-01-06Chardan Capital—Buy—
2026-01-05Wells Fargo—Overweight—
2025-11-05Citizens—Market Outperform—
2025-11-05Chardan Capital—Buy—
2025-10-17Needham—Buy—
2025-10-02Baird—Outperform—
2025-08-13Canaccord Genuity—Buy—
2025-08-13Wells Fargo—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.31$144.8M5
Sun Dec 31$-0.12$203.7M5
Mon Dec 31$0.26$492.8M1
Tue Dec 31$1.02$924.8M1